Reuters exclusively reports UNICEF says AstraZeneca supply problems outside India resolved

Reuters exclusively reported that problems that have delayed AstraZeneca supplies to the COVAX vaccine-sharing facility have been resolved. UNICEF told Reuters that it should receive 65 million doses by end-May from manufacturers outside India. The rollout of COVID vaccines has been disrupted by supply shortfalls in many countries, aggravated by a temporary hold on exports of the inoculation made by the Serum Institute of India (SII) as the country battles to contain a surge in infections.

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Global
Countries: India
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Major Global Story
Sign up for email updates

Sign up for email updates